Tag: Featured

Researchers have published their findings from a study into the ability of two international birthweight standards (customised GROW and INTERGROWTH-21st) to identify perinatal morbidity and mortality indicators associated with small for gestational age. The findings indicated that customised GROW assessments resulted in the increased identification of small for gestational age term babies. More information can be found here. Photo by Cassidy […]

Interim results have been published using data collected in the Biogen Multiple Sclerosis Pregnancy Exposure Registry. This latest study provides safety data for oral delayed-release dimethyl fumarate. More information can be found here. Photo by Robina Weermeijer on Unsplash

Researchers from the University of Copenhagen and Copenhagen University Hospital have published a large population-based observational study investigating the safety of gestational duloxetine use. The study was conducted using data from registers in Sweden and Denmark, and provided reassuring results regarding major congenital malformation and stillbirth risks. More information can be found here.

Researchers from Aalborg University have published a national cohort study investigating the risk of adverse pregnancy outcomes following first trimester anticoagulant exposure. More information can be found here.

Researchers from the OTIS Collaborative Research Group have conducted a prospective study of birth outcomes among 279 women who have taken hydroxycholoroquine in pregnancy. More details can be found here. Photo by Christina Victoria Craft on Unsplash

An interesting case report has described syncytiotrophoblasts as a major cellular target for SARS-CoV-2 infection of the placenta, and suggested that the possible stillbirth risks of placentotropic SARS-CoV-2 may be related to hampered maternal and/or fetal perfusion of the placenta. More information can be found here. Photo by João Paulo de Souza Oliveira on Unsplash